Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.00167
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA